What is BPC-157 + TB-500 Blend?
The BPC-157 + TB-500 blend combines two powerful regenerative peptides that work synergistically in tissue repair processes. BPC-157 (Body Protection Compound 157) is a pentadecapeptide (15 amino acids) derived from a sequence in human gastric juice, discovered by researchers at the University of Zagreb. The full sequence is Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. TB-500 is a synthetic version of Thymosin Beta-4, a naturally occurring 43-amino acid peptide originally isolated from the thymus. These peptides belong to the class of cytoprotective and regenerative peptides that play essential roles in cellular repair processes.
Mechanism of Action
BPC-157 works through multiple mechanisms, including the modulation of angiogenesis by interacting with VEGF receptors and the stabilization of the extracellular matrix. The peptide activates the FAK-paxillin pathway, which is crucial for cell migration and adhesion. It also modulates the NO-pathway and increases the expression of growth factors such as VEGF and PDGF-BB. TB-500 binds to actin, a crucial cytoskeletal protein, and promotes actin polymerization. This facilitates cell mobility and migration, essential for wound healing. The peptide also activates the PI3K/Akt signaling pathway and stimulates the production of matrix metalloproteinases (MMPs), which are involved in tissue remodeling. The combination of both peptides creates a synergistic effect where complementary pathways are activated for optimal tissue regeneration.
Research Results
Preclinical studies have shown promising results for both peptides. A study published in the Journal of Physiology and Pharmacology showed that BPC-157 accelerated the healing of Achilles tendon injuries in rats by 89% compared to control groups. In another study, BPC-157 improved the recovery rate of gastric ulcers by 71% within 14 days of treatment. TB-500 studies, published in the Annals of the New York Academy of Sciences, demonstrated significant improvement in heart function after myocardial infarction in mouse models, with a 34% increase in ejection fraction. Combination studies showed synergistic effects, with simultaneous administration of both peptides yielding superior results compared to individual treatment in models of muscle injury and wound healing.
Available Variants and Purity
Dutch Peptide Labs offers this premium peptide blend in two research variants: 5+5mg for €99 and 10+10mg for €179. Both variants are supplied as lyophilized powder with a guaranteed purity of 99.9%, verified by independent HPLC-MS analysis. Each product comes with a Certificate of Analysis (COA) confirming its exact purity, identity, and sterile production. The peptides are manufactured under strict GMP guidelines in European facilities and undergo extensive quality control before release for research purposes.
Storage and Handling
For optimal stability, the lyophilized powder should be stored at -20°C to -80°C, where it remains stable for at least 2 years. Upon reconstitution with bacteriostatic water or sterile PBS, the solution is stable for 30 days at 2-8°C. For long-term storage of reconstituted solutions, aliquoting and storage at -20°C is recommended. Avoid repeated freezing and thawing. Reconstitution should be done slowly along the side of the vial to prevent foaming. Use sterile techniques and a laminar flow hood if available for optimal product integrity.
Research Disclaimer
This product is intended exclusively for in vitro scientific research by qualified professionals and is NOT suitable for human or animal consumption, therapeutic use, or diagnostic applications. Dutch Peptide Labs bears no responsibility for misuse. Users must adhere to all relevant safety protocols and local regulations when handling this research material.
